My Companies
Notification
Account
Log Out
Login
Q1 FY27 standalone PAT turned positive at ₹14 Cr despite revenue falling 26% YoY, while consolidated EBITDA was ₹36 Cr but PAT remained a ₹44 Cr loss. USA commercial operations are now targeted for December 2026; estimated project cost rose to US$340m, with construction delays affecting funding closure. Context: USA ramp-up remains behind its earlier timeline.
Thirumalai Chemicals Approves ₹750 Crore Fund Raise As Losses Narrow
Thirumalai Chemicals Approves ₹750 Crore Fund Raise For Debt Repayment
Thirumalai Chemicals Board To Consider Equity Fundraise On August 4